UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 104

Sortiert nach

Toward precision prescribing for methadone: Determinants of methadone deposition

PloS one, 2020-04, Vol.15 (4), p.e0231467

2020

Link zum Volltext

Verfügbarkeit prüfen

Effect of CYP2B6, ABCB1, and CYP3A5 Polymorphisms on Efavirenz Pharmacokinetics and Treatment Response: An AIDS Clinical Trials Group Study

The Journal of infectious diseases, 2010-09, Vol.202 (5), p.717-722

2010

Link zum Volltext

Verfügbarkeit prüfen

Multimodal nanoparticles that provide immunomodulation and intracellular drug delivery for infectious diseases

Nanomedicine, 2014-05, Vol.10 (4), p.831-838

2014

Link zum Volltext

Verfügbarkeit prüfen

Safety and Antiviral Activity of the HCV Entry Inhibitor ITX5061 in Treatment-Naive HCV-Infected Adults: A Randomized, Double-Blind, Phase 1b Study

The Journal of infectious diseases, 2014-03, Vol.209 (5), p.658-667

2014

Link zum Volltext

Verfügbarkeit prüfen

Proximal renal tubular function in HIV-infected children on tenofovir disoproxil fumarate for treatment of HIV infection at two tertiary hospitals in Harare, Zimbabwe

PloS one, 2020-07, Vol.15 (7), p.e0235759

2020

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenetics of Long-Term Responses to Antiretroviral Regimens Containing Efavirenz and/or Nelfinavir: An Adult AIDS Clinical Trials Group Study

The Journal of infectious diseases, 2005-12, Vol.192 (11), p.1931-1942

2005

Link zum Volltext

Verfügbarkeit prüfen

Interaction between buprenorphine and atazanavir or atazanavir/ritonavir

Drug and alcohol dependence, 2007-12, Vol.91 (2), p.269-278

2007

Link zum Volltext

Verfügbarkeit prüfen

Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related Disorders

Current vascular pharmacology, 2016-05, Vol.14 (3), p.280

2016

Link zum Volltext

Verfügbarkeit prüfen

HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virus

The Journal of clinical investigation, 2020-11, Vol.130 (11), p.5847-5857

2020

Link zum Volltext

Verfügbarkeit prüfen

Interactions between Buprenorphine and Antiretrovirals. I. The Nonnucleoside Reverse-Transcriptase Inhibitors Efavirenz and Delavirdine

Clinical infectious diseases, 2006-12, Vol.43 (Supplement-4), p.S224-S234

2006

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic Interactions between Buprenorphine and Antiretroviral Medications

Clinical infectious diseases, 2006-12, Vol.43 (Supplement-4), p.S216-S223

2006

Link zum Volltext

Verfügbarkeit prüfen

Interactions between Buprenorphine and Antiretrovirals. II. The Protease Inhibitors Nelfinavir, Lopinavir/Ritonavir, and Ritonavir

Clinical infectious diseases, 2006-12, Vol.43 (Supplement-4), p.S235-S246

2006

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of Atazanavir Oral Absorption by Lansoprazole Gastric Acid Suppression in Healthy Volunteers

Pharmacotherapy, 2006-03, Vol.26 (3), p.341-346

2006

Link zum Volltext

Verfügbarkeit prüfen

Exploring Awareness, Perceptions, and Willingness to Use HIV Pre-Exposure Prophylaxis: A Qualitative Study of Ghanaian Immigrants in the United States

AIDS patient care and STDs, 2022-01, Vol.36 (1), p.8

2022

Link zum Volltext

Verfügbarkeit prüfen

Impact of Tamoxifen on Vorinostat-Induced Human Immunodeficiency Virus Expression in Women on Antiretroviral Therapy: AIDS Clinical Trials Group A5366, The MOXIE Trial

Clinical infectious diseases, 2022-10, Vol.75 (8), p.1389-1396

2022

Link zum Volltext

Verfügbarkeit prüfen

Detection of Nonnucleoside Reverse-Transcriptase Inhibitor-Resistant HIV-1 after Discontinuation of Virologically Suppressive Antiretroviral Therapy

Clinical infectious diseases, 2008-08, Vol.47 (3), p.421-424

2008

Link zum Volltext

Verfügbarkeit prüfen

The impact of herbal remedies on adverse effects and quality of life in HIV-infected individuals on antiretroviral therapy

Journal of infection in developing countries, 2011-02, Vol.5 (1), p.48-53

2011

Link zum Volltext

Verfügbarkeit prüfen

Antiretroviral Therapy Intensification for Neurocognitive Impairment in Human Immunodeficiency Virus

Clinical infectious diseases, 2023-09, Vol.77 (6), p.866-874

2023

Link zum Volltext

Verfügbarkeit prüfen

Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes

Journal of antimicrobial chemotherapy, 2014-08, Vol.69 (8), p.2175-2182

2014

Link zum Volltext

Verfügbarkeit prüfen

Intrahepatic Viral Kinetics During Direct-Acting Antivirals for Hepatitis C in Human Immunodeficiency Virus Coinfection: The AIDS Clinical Trials Group A5335S Substudy

The Journal of infectious diseases, 2020-07, Vol.222 (4), p.601-610

2020

Link zum Volltext

Verfügbarkeit prüfen

Lack of pharmacokinetic interactions between pitavastatin and efavirenz or darunavir/ritonavir

Journal of acquired immune deficiency syndromes (1999), 2014-12, Vol.67 (4), p.390

2014

Link zum Volltext

Verfügbarkeit prüfen

A Randomized Trial of 2 Different 4-Drug Antiretroviral Regimens versus a 3-Drug Regimen, in Advanced Human Immunodeficiency Virus Disease

The Journal of infectious diseases, 2003-09, Vol.188 (5), p.625-634

2003

Link zum Volltext

Verfügbarkeit prüfen

A Randomized Controlled Trial of Mentoring Interventions for Underrepresented Minorities

Academic medicine, 2016-07, Vol.91 (7), p.994-1001

2016

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of a psychological intervention delivered by general nurses for alcohol use disorders in people living with HIV in Zimbabwe: a cluster randomized controlled trial

Journal of the International AIDS Society, 2020-12, Vol.23 (12), p.e25641-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Genomewide association study of atazanavir pharmacokinetics and hyperbilirubinemia in AIDS Clinical Trials Group protocol A5202

Pharmacogenetics and genomics, 2014-04, Vol.24 (4), p.195-203

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 104

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(97)
Mit Volltextzugriff
(73)

Publikationsform

Artikel
(104)

Sprache

Englisch
(104)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Humans
(103)
Science & Technology
(101)
Life Sciences & Biomedicine
(100)
Male
(98)
Adult
(79)
Middle Aged
(57)
Biological And Medical Sciences
(52)
Medical Sciences
(52)
Pharmacology & Pharmacy
(50)
Hiv Infections - Drug Therapy
(48)
Infectious Diseases
(45)
Pharmacology. Drug Treatments
(41)
Hiv
(37)
Human Immunodeficiency Virus
(37)
Microbiology
(33)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(32)
Antiviral Agents
(30)
Immunology
(27)
Drug Interactions
(25)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Toward precision prescribing for methadone: Determinants of methadone deposition

Effect of CYP2B6, ABCB1, and CYP3A5 Polymorphisms on Efavirenz Pharmacokinetics and Treatment Response: An AIDS Clinical Trials Group Study

Multimodal nanoparticles that provide immunomodulation and intracellular drug delivery for infectious diseases

Safety and Antiviral Activity of the HCV Entry Inhibitor ITX5061 in Treatment-Naive HCV-Infected Adults: A Randomized, Double-Blind, Phase 1b Study

Proximal renal tubular function in HIV-infected children on tenofovir disoproxil fumarate for treatment of HIV infection at two tertiary hospitals in Harare, Zimbabwe

Pharmacogenetics of Long-Term Responses to Antiretroviral Regimens Containing Efavirenz and/or Nelfinavir: An Adult AIDS Clinical Trials Group Study

Interaction between buprenorphine and atazanavir or atazanavir/ritonavir

Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related Disorders

HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virus

Interactions between Buprenorphine and Antiretrovirals. I. The Nonnucleoside Reverse-Transcriptase Inhibitors Efavirenz and Delavirdine

Pharmacokinetic Interactions between Buprenorphine and Antiretroviral Medications

Interactions between Buprenorphine and Antiretrovirals. II. The Protease Inhibitors Nelfinavir, Lopinavir/Ritonavir, and Ritonavir

Inhibition of Atazanavir Oral Absorption by Lansoprazole Gastric Acid Suppression in Healthy Volunteers

Exploring Awareness, Perceptions, and Willingness to Use HIV Pre-Exposure Prophylaxis: A Qualitative Study of Ghanaian Immigrants in the United States

Impact of Tamoxifen on Vorinostat-Induced Human Immunodeficiency Virus Expression in Women on Antiretroviral Therapy: AIDS Clinical Trials Group A5366, The MOXIE Trial

Detection of Nonnucleoside Reverse-Transcriptase Inhibitor-Resistant HIV-1 after Discontinuation of Virologically Suppressive Antiretroviral Therapy

The impact of herbal remedies on adverse effects and quality of life in HIV-infected individuals on antiretroviral therapy

Antiretroviral Therapy Intensification for Neurocognitive Impairment in Human Immunodeficiency Virus

Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes

Intrahepatic Viral Kinetics During Direct-Acting Antivirals for Hepatitis C in Human Immunodeficiency Virus Coinfection: The AIDS Clinical Trials Group A5335S Substudy

Lack of pharmacokinetic interactions between pitavastatin and efavirenz or darunavir/ritonavir

A Randomized Trial of 2 Different 4-Drug Antiretroviral Regimens versus a 3-Drug Regimen, in Advanced Human Immunodeficiency Virus Disease

A Randomized Controlled Trial of Mentoring Interventions for Underrepresented Minorities

Effectiveness of a psychological intervention delivered by general nurses for alcohol use disorders in people living with HIV in Zimbabwe: a cluster randomized controlled trial

Genomewide association study of atazanavir pharmacokinetics and hyperbilirubinemia in AIDS Clinical Trials Group protocol A5202

Aktive Filter

Suchergebnisse filtern